Beyond the NGS Report: Practical Interpretation for Lung Cancer Care

About the TOGA Virtual NGS Report:

This interactive webinar is designed to help medical oncologists and multidisciplinary teams confidently interpret lung cancer molecular pathology reports in real-world clinical practice, especially in settings without access to a molecular tumour board. Through real report examples and case-based discussions, the session covers molecular testing at diagnosis and progression, reading and interpreting reports (including actionable mutations, PD-L1, TMB, and complex molecular scenarios), common pitfalls, and red flags that warrant discussion with pathology or the MDT. Attendees will also explore how to translate these results into evidence-based treatment decisions, supporting the quality use of medicines and improved patient outcomes.

This educational program is supported by a sponsorship provided by Merck.

First Name

Last Name

Mobile

Organisation

Position

State

Country (if outside Australia)

Zip Code

Zip

Specialty/Discipline

If 'Other', please specify:

How did you hear about the event?

If 'Other', please specify:

Chair:

Dr Ben Kong

Medical Oncologist, Prince of Wales Hospital

Dr Ben Kong is a Medical Oncologist at Prince of Wales Hospital and Senior Research Fellow with the SPHERE Cancer Clinical Academic Group at the University of New South Wales. Ben trained in General Medicine within the Nepean/Concord network and Medical Oncology at Westmead Hospital, prior to completing a PhD in Cancer Immunology at the University of Sydney evaluating strategies to combine immune checkpoint inhibitors with cellular therapies. Ben gained experience in clinical trials development, including investigator initiated tumour agnostic and biomarker driven trials, as a Research Fellow at the NHMRC Clinical Trials Centre. He continues to apply his training to translational research interests in thoracic, head and neck cancers and brain metastases.

Presenters:

	Prof Stephen Fox Director of Pathology and Group Leader, Peter MacCallum Cancer Centre Deputy Director, Collaborative Centre for Genomic Cancer Medicine, University of Melbourne Stephen Fox is Director of Pathology at the Peter MacCallum Cancer Centre and Professorial Fellow at the University of Melbourne. He holds Honours degree and Medical degrees from the University of Bristol, UK and a DPhil in Medicine from the University of Oxford. He has Fellowships of both the Royal College of Pathologists Australasia (RCPA) and UK and is also a Founding Fellow of the Faculty of Science. He is an NHMRC Leadership Fellow and a Fellow of the Australian Academy of Health and Medical Sciences. He is an expert member of the WHO Classification of Breast Tumours and has a research interest in diagnostic and predictive markers in breast and other tumour types using protein and nucleic acid-based assays.
	A/Prof Caroline Cooper Anatomical Pathologist Pathology Queensland, Princess Alexandra Hospital A/Prof Cooper BMedSci, MB, BS (Hons), FRCPA, GCertHE, MPhil is a Senior Anatomical Pathologist and Co-Medical Director, working for Pathology Queensland at Princess Alexandra Hospital (PAH), Brisbane, Queensland. She graduated in medicine from the University of Tasmania and undertook specialist Anatomical Pathology training at Westmead and Royal Prince Alfred Hospitals in Sydney. A/Prof Cooper is President-Elect of the Australasian Division of the International Academy of Pathology and Director of the International Collaboration on Cancer Reporting. A/Prof Cooper has a special interest in Pulmonary, Gastrointestinal and Head and Neck pathology. Her research focuses on biomarkers in cancer, including prediction of response to immune checkpoint inhibitors.
	Dr Jennifer Borowsky Anatomical and Molecular Pathologist Pathology Queensland, Princess Alexandra Hospital Jennifer Borowsky, MBChB, PhD, FRCPA, graduated with a Bachelor of Medicine and Surgery in 2008 and was awarded Fellowship of the Royal Australasian College of Pathologists in Anatomical Pathology in 2016. She completed a fellowship in Gastrointestinal and Liver Pathology at Massachusetts General Hospital and Dana Farber Cancer Institute in Boston in 2017. She concurrently commenced and has completed a PhD in the molecular pathobiology of colorectal cancer and continues to publish in this field through appointments to the Conjoint Gastroenterology Group at the Queensland Institute of Medical Research (QIMR) and national and international collaborations. Jennifer is a Senior Pathologist and co-director of Anatomical Pathology at the Princess Alexandra Hospital as well as Molecular Pathologist at the Royal Brisbane Hospital overseeing molecular sequencing of solid tumours.
	A/Prof Malinda Itchins Medical Oncologist Royal North Shore Hospital and Chris O'Brien Lifehouse A/Prof Malinda Itchins BMedSci, MBBS(Hons1), FRACP, PhD, is a thoracic medical oncologist at Royal North Shore Hospital, and Chris O'Brien Lifehouse, Sydney. She is a senior clinical lecturer with the University of Sydney and Board Director with the Clinical Oncology Society of Australia (COSA). Malinda is Co-Chair of the Advanced NSCLC Group on the Scientific Committee of the Thoracic Oncology Group of Australasia (TOGA), and passionate trialist, researcher and advocate for improving care for all people affected by lung cancer.
	Dr Lavinia Tan Medical Oncologist Peter MacCallum Cancer Centre Dr Lavinia Tan is a Medical Oncologist with a sub-speciality interest in treating patients with lung cancer. She completed a clinical fellowship focusing on thoracic malignancies at the Peter MacCallum Cancer Centre and a laboratory-based PhD exploring the utility of circulating tumour DNA to guide precision medicine in solid malignancies. Lavinia’s main research interests focus on understanding how lung cancers evolve and developing novel strategies to overcome resistance to targeted therapies in oncogene driven lung cancers.

You need to enable JavaScript to access this site.

Follow these instructions on how to enable JavaScript.

Internet Explorer

Select Tools from the top menu
Choose Internet Options
Click on the Security tab
Click on Custom Level
Scroll down until you see the section labelled Scripting
Under Active Scripting, select Enable and click OK

Google Chrome

Select the menu icon on the browser toolbar
Select Settings
Click the Show advanced settings... link then Content Settings in the Privacy section
Select Allow all sites to run JavaScript (recommended) and click Done

Safari (Mac)

Select Safari from the top menu
Choose Preferences
Choose Security
Select the checkbox next to Enable JavaScript

PROGRAM *Chair: Dr Ben Kong* 6:30 PM – 8:00 PM AEST
Time	Topic	Speaker
6:30 PM – 6:35 PM	Welcome & Overview	Chair: Dr Ben Kong
6:35 PM – 6:55 PM	Molecular Testing at Diagnosis	Prof Stephen Fox
6:55 PM – 7:15 PM	How to Read a Lung Cancer Molecular Report	A/Prof Caroline Cooper Dr Jennifer Borowsky
7:15 PM – 7:35 PM	Translating Results into Treatment Decisions	A/Prof Malinda Itchins
7:35 PM – 7:50 PM	Molecular Testing at Progression	Dr Lavinia Tan
7:50 PM – 8:00 PM	Panel Discussion	All Speakers
8:00 PM	Closing	Chair: Dr Ben Kong

Beyond the NGS Report: Practical Interpretation for Lung Cancer Care

Beyond the NGS Report: Practical Interpretation for Lung Cancer Care

Dr Ben Kong

Prof Stephen Fox

A/Prof Caroline Cooper

Dr Jennifer Borowsky

A/Prof Malinda Itchins

Dr Lavinia Tan